Thomas P. Ahern
Impact in
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Cancer, Lipids, and Metabolism 14
- Breast Cancer Treatment Studies 8
- Oncology 16
- Cancer Risks and Factors 6
- Co-authors
- Timothy L. Lash (56 shared papers)Deirdre Cronin‐Fenton (47 shared papers)Henrik Toft Sørensen (38 shared papers)Lars Pedersen (9 shared papers)Per Damkier (28 shared papers)Rebecca A. Silliman (12 shared papers)Peer Christiansen (19 shared papers)Jens Peter Garne (9 shared papers)
- Journals
- Acta Oncologica (10 papers)Breast Cancer Research and Treatment (8 papers)Cancer Epidemiology Biomarkers & Prevention (8 papers)American Journal of Epidemiology (7 papers)Epidemiology (6 papers)
- Partner nations
- United StatesDenmarkSweden
In The Last Decade
Thomas P. Ahern
101 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 126
- Cancer Research 783
- Pharmacology 190
- Oncology 436
- Psychiatry and Mental health 192
- Health, Toxicology and Mutagenesis 170
Countries citing papers authored by Thomas P. Ahern
This map shows the geographic impact of Thomas P. Ahern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Ahern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Ahern more than expected).
Fields of papers citing papers by Thomas P. Ahern
This network shows the impact of papers produced by Thomas P. Ahern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Ahern. The network helps show where Thomas P. Ahern may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas P. Ahern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 308 | |
| 2 | 2014 | 154 | |
| 3 | 2018 | 148 | |
| 4 | 2017 | 101 | |
| 5 | 2019 | 95 | |
| 6 | 2013 | 90 | |
| 7 | 2015 | 80 | |
| 8 | 2011 | 77 | |
| 9 | 2018 | 77 | |
| 10 | 2010 | 74 | |
| 11 | 2008 | 60 | |
| 12 | 2008 | 55 | |
| 13 | 2008 | 49 | |
| 14 | 2009 | 43 | |
| 15 | 2018 | 39 | |
| 16 | 2021 | 36 | |
| 17 | 2021 | 35 | |
| 18 | 2020 | 34 | |
| 19 | 2016 | 34 | |
| 20 | 2014 | 33 |
About Thomas P. Ahern
Thomas P. Ahern is a scholar working on Cancer Research, Oncology, Genetics, Surgery and Pulmonary and Respiratory Medicine, having authored 109 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (14 papers), Estrogen and related hormone effects (12 papers), Pharmacogenetics and Drug Metabolism (9 papers), Breast Cancer Treatment Studies (8 papers), Effects and risks of endocrine disrupting chemicals (8 papers), Advanced Causal Inference Techniques (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Cancer Risks and Factors (6 papers). The work is most often cited by research in Cancer Research (783 citations), Pharmacology (190 citations), Oncology (436 citations), Psychiatry and Mental health (192 citations) and Health, Toxicology and Mutagenesis (170 citations). Thomas P. Ahern has collaborated with scholars based in United States, Denmark and Sweden. Frequent co-authors include Timothy L. Lash, Deirdre Cronin‐Fenton, Henrik Toft Sørensen, Lars Pedersen, Per Damkier, Rebecca A. Silliman, Peer Christiansen, Jens Peter Garne, Signe Borgquist and T. L. Lash. Their work appears in journals such as Acta Oncologica, Breast Cancer Research and Treatment, Cancer Epidemiology Biomarkers & Prevention, American Journal of Epidemiology and Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.